Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
09/14/2005 | EP1572870A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use |
09/14/2005 | EP1572866A2 Insect nuclear receptor genes and uses thereof |
09/14/2005 | EP1572861A2 Ap1 amine oxidase variants |
09/14/2005 | EP1572859A2 Dispersion of carbon nanotubes by nucleic acids |
09/14/2005 | EP1572744A2 Immunoglobulin variants and uses thereof |
09/14/2005 | EP1572741A1 Therapeutic and diagnostic agents |
09/14/2005 | EP1572730A2 Nact as a target for lifespan expansion and weight reduction |
09/14/2005 | EP1572712A2 Cancer-linked gene as target for chemotherapy |
09/14/2005 | EP1572363A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon |
09/14/2005 | EP1572235A2 Methods of therapy and diagnosis using targeting of cells that express lax |
09/14/2005 | EP1572130A2 Compositions and methods for the treatment of immune related diseases |
09/14/2005 | EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
09/14/2005 | EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
09/14/2005 | EP1572080A2 Fgf variants and methods for use thereof |
09/14/2005 | EP1572072A2 Methods of treating infection by drug resistant bacteria |
09/14/2005 | EP1572067A2 Conjugates and compositions for cellular delivery |
09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
09/14/2005 | EP1571909A2 Optimized multi-epitope constructs and uses thereof |
09/14/2005 | EP1109915B1 Nucleotide sequences for the tal gene |
09/14/2005 | EP1013665B1 Polypeptide having water channel activity and dna sequence |
09/14/2005 | CN1668765A Oligonucleotides for detecting microorganisms |
09/14/2005 | CN1668742A Solid support having electrostatic layer and use thereof |
09/14/2005 | CN1668635A Novel calpastatin (CAST) alleles |
09/14/2005 | CN1668629A Modulation of the expression of genes dependent on STAT-1 |
09/14/2005 | CN1667123A Gene cluster responsible for synthesis of FR-008 polyketone antibiotics |
09/14/2005 | CN1219066C Phycoerythrin beta and alpha subunit gene promotor, and preparing method and use thereof |
09/14/2005 | CN1219059C Rice flavamonocell hrf2 gene, recombinant vector and method for transgenic breeding plant therefor |
09/14/2005 | CN1218959C Paddy rice ethylene receptor protein, coded gene and use thereof |
09/14/2005 | CN1218954C Human hematopoietic cell relative gene-1 |
09/13/2005 | US6943243 Control of gene expression in eukaryotic cells |
09/13/2005 | US6943242 Design of artificial genes for use as controls in gene expression analysis systems |
09/13/2005 | US6943034 Combinatorial strategies for polymer synthesis |
09/13/2005 | US6943027 Contacting a nucleic acid with an organic polycation to produce a condensed nucleic acid, and then combining product with an amphiphilic cationic lipid; increased shelf life and high transfection activity |
09/13/2005 | US6943020 Death domain containing receptor-4 antibodies |
09/13/2005 | US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta |
09/13/2005 | US6942974 Methods and kits for the sequential elution of families of extension products from one or more substrates |
09/13/2005 | US6942972 Preparation of oligonucleotide-protein conjugate; obtain oligonucleotide expose to linker, join, expose oligonucleotide-linker conjugate with preferential protein, join, recover oligonucleotide-protein conjugate |
09/13/2005 | US6942971 Apparatus for analysis of a nucleic acid amplification reaction |
09/13/2005 | US6942968 A layout comprising substrate with an array of geometrically shaped well, containing bioactive agent and signal transducer element, surfaces coated with reflective spectrum absorptive coatings, for detecting a target analyte in a sample |
09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
09/13/2005 | US6942964 Tracer reagents that enhance reaction-product analysis |
09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
09/13/2005 | CA2123686C Method for exponential amplification of nucleic acid by a single unpaired primer |
09/09/2005 | WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression |
09/09/2005 | WO2005083084A1 Intercalating triplex forming oligonucleotide derivatives and process for the preparation thereof |
09/09/2005 | WO2005083073A1 Dna enzyme and method of controlling the activity thereof |
09/09/2005 | WO2005082932A2 Compositions and methods using rna interference for control of nematodes in plants |
09/09/2005 | WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
09/09/2005 | WO2005082923A1 Novel method of synthesizing nucleic acid without protecting nucleotide bases |
09/09/2005 | WO2005082922A1 Oligonucleotides related to lipid membrane attachments |
09/09/2005 | WO2005082921A1 Method for inhibiting cellular proliferation |
09/09/2005 | WO2005082098A2 Polony fluorescent in situ sequencing beads |
09/09/2005 | WO2005082073A2 Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (cxcr2) single nucleotide polymorphism |
09/09/2005 | WO2005082020A2 Flavivirus vaccines |
09/09/2005 | WO2005081854A2 Egf receptor epitope peptides and uses thereof |
09/09/2005 | WO2005081714A2 Use of interfering rna in the production of transgenic animals |
09/09/2005 | WO2005062947A3 Methods and compositions for identifying rna-binding proteins |
09/09/2005 | WO2005058957A3 Ztnf 12, a tumor necrosis factor |
09/09/2005 | WO2005051994A3 Ztnf11, a tumor necrosis factor |
09/09/2005 | WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds |
09/09/2005 | WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins |
09/09/2005 | WO2005046708A8 Selective inhibitors of nuclear factor-kb activation and uses thereof |
09/09/2005 | WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain |
09/09/2005 | WO2005037850A3 Solid phase methods for polynucleotide production |
09/09/2005 | WO2005036169A3 Fluorescent probes for ribosomes and method of use |
09/09/2005 | WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
09/09/2005 | WO2005033265A3 Optimized multi-epitope constructs and uses thereof |
09/09/2005 | WO2005024045A3 Primers for use in detecting beta-lactamases |
09/09/2005 | WO2005014782A3 Double-stranded ribonucleic acid with increased effectiveness in an organism |
09/09/2005 | WO2005000220A8 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
09/09/2005 | WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
09/09/2005 | WO2004085608A3 Methods for high throughput elucidation of transcriptional profiles and genome annotation |
09/09/2005 | CA2558666A1 Salivary mrna profiling, biomarkers, and related methods and kits of parts |
09/09/2005 | CA2558581A1 Novel method for the synthesis of nucleic acid without protecting base moiety |
09/09/2005 | CA2558256A1 Oligonucleotides related to lipid membrane attachments |
09/09/2005 | CA2557841A1 Polony fluorescent in situ sequencing beads |
09/09/2005 | CA2557508A1 Compositions and methods for the systemic treatment of arthritis |
09/09/2005 | CA2557136A1 Flavivirus vaccines |
09/09/2005 | CA2556632A1 Egf receptor epitope peptides and uses thereof |
09/09/2005 | CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
09/09/2005 | CA2555245A1 Antisense oligonucleotide modulation of stat3 expression |
09/09/2005 | CA2546853A1 Use of interfering rna in the production of transgenic animals |
09/09/2005 | CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis |
09/08/2005 | US20050198711 Indeterminate gametophyte 1 (ig1), mutations of ig1, orthologs of ig1, and uses thereof |
09/08/2005 | US20050198710 Method of improving soybean protein color by reducing levels of flavonol |
09/08/2005 | US20050198699 Knockin non-human animal and tissue-specific MnSOD knockout non-human animal |
09/08/2005 | US20050198695 Nematode ATP synthase subunit E-like sequences |
09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
09/08/2005 | US20050197316 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
09/08/2005 | US20050197313 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
09/08/2005 | US20050197311 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
09/08/2005 | US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease |
09/08/2005 | US20050197309 Antisense modulation of dual specific phosphatase 5 expression |
09/08/2005 | US20050197305 Methods and compositions for blocking progression of a disease state |
09/08/2005 | US20050197298 Water soluble, prevention of neovascularization |
09/08/2005 | US20050197293 Use of an IL-1 antagonist for treating arthritis |
09/08/2005 | US20050196856 Polyelectrolyte-coated size-exclusion ion-exchange particles |
09/08/2005 | US20050196853 Alpha-amylase variants |
09/08/2005 | US20050196840 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
09/08/2005 | US20050196836 Gamma-glutamylcysteine producing yeast |